References
- Afdhal, N.H., Nunes, D. (2004). Evaluation of liver fibrosis: A concise rerview. Amer. J. Gastroenterol., 99, 1160-1174.10.1111/j.1572-0241.2004.30110.x
- Bedossa, P. (2009). Assessment of hepatitis C: Non-invasive fibrosis markers and/or liver biopsy. Liver Internat., 29 (S. 1), 19-22.10.1111/j.1478-3231.2008.01940.x
- Bedossa, P., Carrat, F. (2009). Liver biopsy: The best, not the gold standard. J. Hepatology, 50(1), 1-3.10.1016/j.jhep.2008.10.014
- Bennett, M.R. (2002). Apoptosis in the cardiovascular system. Heart, 87(5), 480-487.10.1136/heart.87.5.480
- Bottero, J., Lacombe, K., Guéchot, J., Serfaty, L., Miailhes, P., Bonnard, P., Wendum, D., Molina, J.-M., Lascoux-Combe, C., Girard, P.-M. (2009). Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J. Hepatol., 50(6), 1074-1083.10.1016/j.jhep.2009.01.022
- Colli, A., Fraquelli, M. (2009). What is the actual role of diagnosis and how to assess it? J. Hepatol., 50(4), 827-829.10.1016/j.jhep.2008.12.012
- Colloredo, G., Guido, M., Sonzogni, A. & Leandro, G. (2003). Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J. Hepatology, 39, 239-244.10.1016/S0168-8278(03)00191-0
- Gavrieli, Y., Sherman, Y., Ben-Sasson, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501.10.1083/jcb.119.3.49322896651400587
- Guesdon, J.L., Ternynsk, T., Avrameas, S. (1979). The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem., 27, 1131-1139.10.1177/27.8.9007490074
- Holmgren, L., O'Reilly, M.S., Folkman, J. (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1, 149-153.10.1038/nm0295-1497585012
- Kawamoto, M., Mizuquchi, T., Katsuramaki, T., Nagayama, M., Oshima, H., Kawasaki, H., Nobuoka, T., Kimura, Y., Hirata, K. (2006). Assessment of liver fibrosis by non invasive method of transient elastography and biochemical markers. World J. Gastroenterol., 12(27), 4325-4330.10.3748/wjg.v12.i27.4325
- Lackner, C., Struber, G., Liegl, B., Leibl, S., Ofner, P., Bankuti, C., Baner, B., Stanber, R.E. (2005). Comparison and validation of simple noninvasive tests for predication of fibrosis in chronic hepatitis C. Hepatology, 100, 868-873.
- Manning, D.S., Afdhal, N.H. (2008). Diagnosis and quantitation of fibrosis. Gastroenterology, 134, 960-974.10.1053/j.gastro.2008.03.001
- Mehta, S.H., Lau, B., Afdol, N.H., Thomas, D.L. (2009). Exceeding the limits of liver histology markers. J. Hepatology, 50(1), 36-41.10.1016/j.jhep.2008.07.039
- Reed, J.C. (2000). Warner-Lambent/Parke-Davis awards lecture: Mechanisms of apoptosis. Amer. J. Pathol., 157, 1415-1430.10.1016/S0002-9440(10)64779-7
- Regev, A., Berho, M., Jeffers, L.Z., Milikowski, C., Molina, E.G., Pyrsopoulos, N.T., Feng Z., Reddy, K.R., Schiff, E.R. (2002). Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Amer. J. Gastroenterol., 97, 2614-2618.10.1111/j.1572-0241.2002.06038.x12385448
- Rousselet, M.C., Michalak, S., Dupre, F., Croué, A., Bedossa, P., Saint-André, J.P., Cales, P. (2005). Sources of variability in histological scoring of chronic viral hepatitis. Hepatology, 41, 257-264.10.1002/hep.2053515660389
- Schattenbeg, J.M., Galle, P.R., Schuchmann, M. (2006). Apoptosis in liver disease. Liver Internat., 26(8), 904-911.10.1111/j.1478-3231.2006.01324.x16953829
- Schinoni, M.I., Paranī, R., Cavalcante, D. (2006). Apoptosis and progression of hepatic fibrosis in hepatitis C patients. Braz. J. Infect. Dis., 10(2), 117-121.10.1590/S1413-86702006000200009
- Suzuki, A., Mendes, F., Lindor, K. (2005). Diagnostic model of esophageal varices in alcoholic liver disease. Eur. J. Gastroenterol. Hepatol., 17(3), 307-309.10.1097/00042737-200503000-0000815716654